Ridgeback Capital

Summary

The main office of represented VC is situated in the New York. The company was established in North America in United States.

We also calculated 1 valuable employee in our database.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Adaptimmune, 4D Molecular Therapeutics, Stem Cell Therapeutics. We can highlight the next thriving fund investment areas, such as Industrial, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. Deals in the range of 50 - 100 millions dollars are the general things for fund. The increased amount of exits for fund were in 2019. The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Ridgeback Capital works on 60 percentage points more the average amount of lead investments.

The usual cause for the fund is to invest in rounds with 9-10 partakers. Despite the Ridgeback Capital, startups are often financed by Polaris Partners, UBS Asset Management, Remeditex Ventures. The meaningful sponsors for the fund in investment in the same round are venBio Partners, OrbiMed, F-Prime Capital. In the next rounds fund is usually obtained by Eight Roads Ventures, Cancer Prevention and Research Institute of Texas.